The global market size of radiotherapy devices is estimated to cross US$ 7.5 billion by 2022 and will register a CAGR of more than 6% in the forecast period. This growth is majorly due to the rising number of cancer patients, rapidly changing cancer treatment technology, and increasing adoption of radiotherapy devices and procedures. The restraining factors of global radiotherapy devices market include the lack of adequate infrastructure, high healthcare expenditure, shortage of adequate skills and training, availability of alternative treatment procedures.
The global radiotherapy devices market is segmented by type, technology, application, and region. The type, technology, application segments are further classified into external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiotherapy is expected to dominate the global market in 2017. Based on technology, the external beam radiation therapy segmentation is classified into image guided radio therapy, 3-D conformal radiotherapy, intensity modulated radiation therapy, tomotherapy, adaptive radiation therapy, and others.
The internal beam radiation therapy includes low-dose rate and high-dose rate. Based on application, the external beam radiation therapy segment is classified into prostate cancer, head and neck cancer, breast cancer, spine cancer, lung cancer and brain cancer. Prostate cancer is estimated to dominate both the external as well as the internal radiotherapy market in 2017. The internal beam radiation therapy includes gynecological cancer, esophageal cancer, penile cancer and cervical cancer. North America, Europe, Asia Pacific, and RoW are the regional segments of the market. Each regional market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and the GCC countries. Asia Pacific is projected to register the highest CAGR during the forecast period. Increasing incidence of cancer cases is the driving factor of the market in the region.
A glimpse of the report structure is provided in the report description available on the website.
The key players profiled in the report include Varian Medical System, Accuray, Inc., Elekta AB, and IsoRay Medical, Inc. Other players include IBA Group (Belgium), Eckert & Ziegler BEBIG (Belgium), iCAD, Inc. (U.S.), GE Healthcare (U.K.), Covidien, PLC (Ireland), C.R. Bard, Inc. (U.S.), Nordion, Inc. (Canada), Theragenics Corporation (U.S.), Oncura, Inc. (U.S.). A detailed competitive landscape of these companies is provided with company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The deep-dive study on the global radiotherapy devices market will help customers with identifications of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org